MattRezaKhoshnevisMD
Pulmonology • Houston, TXCritical Care Medicine, Interventional Pulmonology, Pleural Disease
Associate Program Director, Pulmonary & Critical care fellowship, Houston Methodist Hospital, Weill Cornell Medical College
Dr. Khoshnevis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6565 Fannin St
# Fondren
Houston, TX 77030Phone+1 713-441-3020Fax+1 713-793-7064
Summary
- Dr. Matt Khoshnevis is a pulmonologist in Houston, TX and is affiliated with Houston Methodist Hospital. He received his medical degree from Shahid Beheshti University of Medical Sciences and has been in practice 23 years. He also speaks multiple languages, including Farsi. He specializes and is experienced in general pulmonology, critical care medicine, interventional pulmonology, pleural disease and sleep medicine. Dr Khoshnevis is currently the Associate Program Director for Pulmonary & Critical Care Fellowship at Houston Methodist Hospital
Education & Training
Baylor College of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2000 - 2003- Baylor College of MedicineResidency, Internal Medicine, 1997 - 2000
Shahid Beheshti University of Medical SciencesClass of 1994
Certifications & Licensure
MI State Medical License 2000 - 2026
CA State Medical License 2003 - 2025
IN State Medical License 2000 - 2025
KS State Medical License 2000 - 2025
TX State Medical License 2001 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
- American Board of Internal Medicine Sleep Medicine
Publications & Presentations
PubMed
- 11 citationsIntravenous ravulizumab in mechanically ventilated patients hospitalised with severe COVID-19: a phase 3, multicentre, open-label, randomised controlled trial.Djillali Annane, Sean J Pittock, Hrishikesh S Kulkarni, Brian W Pickering, Matt R Khoshnevis
The Lancet. Respiratory Medicine. 2023-12-01
Professional Memberships
- Member
- Fellow
- Member
- Society of Critical Care MedicineMember
- American Academy of Bronchology and Interventional pulmonologyMember
- Society of Thoracic Radiology (STR)Member
Other Languages
- Farsi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
